Stemline Therapeutics (STML) PT Lowered to $11 at Wedbush

March 17, 2020 6:08 AM EDT
Get Alerts STML Hot Sheet
Price: $11.83 --0%

Rating Summary:
    6 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 11 | Down: 8 | New: 46
Trade Now! 
Join SI Premium – FREE
Wedbush analyst David Nierengarten lowered the price target on Stemline Therapeutics (NASDAQ: STML) to $11.00 (from $14.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change